The deadline to file a claim for faulty DePuy ASR hip implant injuries has been extended to accommodate an estimated 1,400 patients. Johnson & Johnson has now agreed to pay an additional $420 million to plaintiffs who underwent implant removal surgery through Jan. 31, 2015.
The original settlement only covered patients who had removal surgery through August, 31, 2013.
According to Bloomberg, DePuy made the announcement in response to growing pressure from plaintiffs’ attorneys and as an alternative to “protracted litigation.” A federal court filing in Toledo, Ohio shows that, under the same terms of the original U.S. Settlement Plan, if you had a DePuy ASR hip implant device removed before Jan. 31, 2015, you may be eligible to receive up to $300,000 in compensation from Johnson & Johnson.
After all funds have been distributed, Johnson & Johnson will have paid out a total of $4 billion in damages related to its DePuy ASR hip implant device.
Johnson & Johnson originally recalled 93,000 DePuy ASR hip implant devices due to high failure rates. While the devices were said to last 20 years and provide patients with an increased range of motion and lessen pain, some patients began experiencing signs of metal poisoning due to the device’s metal-on-metal design.
These plaintiffs filed lawsuits alleging, among other claims, that the metal ball and socket design of the hip caused chromium and cobalt ions to be deposited into the patient’s bloodstream, sickening them with toxic chemicals. Plaintiffs further allege that they were forced to have additional surgeries to remove the faulty devices.